KR930012742A - 광학활성의 불소함유 화합물 - Google Patents

광학활성의 불소함유 화합물 Download PDF

Info

Publication number
KR930012742A
KR930012742A KR1019920025150A KR920025150A KR930012742A KR 930012742 A KR930012742 A KR 930012742A KR 1019920025150 A KR1019920025150 A KR 1019920025150A KR 920025150 A KR920025150 A KR 920025150A KR 930012742 A KR930012742 A KR 930012742A
Authority
KR
South Korea
Prior art keywords
containing compound
group
optically active
compound according
trifluoromethyl
Prior art date
Application number
KR1019920025150A
Other languages
English (en)
Other versions
KR970011461B1 (ko
Inventor
마사아끼 나메가와
신이찌 나유끼
게이조 이또
미쓰노리 다께다
요시노부 무라야마
Original Assignee
고하다 하지로
가시마 세끼유 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 고하다 하지로, 가시마 세끼유 가부시끼가이샤 filed Critical 고하다 하지로
Publication of KR930012742A publication Critical patent/KR930012742A/ko
Application granted granted Critical
Publication of KR970011461B1 publication Critical patent/KR970011461B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/02—Liquid crystal materials characterised by optical, electrical or physical properties of the components, in general
    • C09K19/0225—Ferroelectric
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3402—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom
    • C09K2019/3422—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having oxygen as hetero atom the heterocyclic ring being a six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

일반식(Ⅰ)
식중 Rf는 탄소수 1 또는 2플루오르 알킬기를 나타내고, R1, R2 및 R3은 각각 독립적으로 수소, 1-15의 곧은 사슬 또는 분지사슬 알킬기. 탄소수 2-15의 알케닐기, 또는 탄소수 7-10의 아랄킬기를 나타내고, 호는 비대칭 탄소원자를 나타낸다. 상기 한 화합물은 테트라 히드로피란 고리상의 비대칭 탄소 원자에 그 자체로 큰 전자 흡인성을 갖는 플루오르 알킬기틀 갖고 있다. 테트라 히드로-6-트리플루오르메틸-2-헥실옥시-4-메틸-5-히드록시 피란은 효소저해제 생물 활성물질 항암제 및 강유전성 액정등의 원료로서 광범한 이용이 기대되는 것이 에증되었다.

Description

광학활성의 불소함유 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 일반식(Ⅰ)
    [식중, Rf는 탄소수 1또는 2플루오르 알킬기를 나타내고, R1,R2및 R3은 각각 독립적으로수소, 탄소수 1-15의 곧은사슬 또는 분지사슬 알킬기. 탄소수 2-15의 알케닐기, 또는 탄소수 7-10의 아릴킬기를 나타내고, *는 비대칭 탄소원자를 나타낸다.]로 표시되는 광학 활성의 불소함유 화합물.
  2. 제1항에 있어서, Rf가 트리플루오르메틸기, 디플루오르메틸기, 클로로 디플루오르메틸기, 펜타플루오르에틸기 중에서 선택된 것을 특징으로 하는 광학활성의 불소함유 화합물.
  3. 제1항에 있어서, Rf가 트리플루오르 메틸기인 것을 특징으로 하는 광학 활성의 불소 함유 화합물.
  4. 제1항에 있어서, R2,R3가 수소원자인 것을 특징으로 하는 광학 활성의 볼소함유 화합물.
  5. 제1항에 있어서, R2가 수소원자인 것을 특징으로 하는 광따 활성의 볼소함유 화합물.
  6. 제1항에 있어서, R3이 수소원자인 것을 특징으로 하는 광학 활성의 불소함유 화합물.
  7. 제1항에 있어서. 화합물이 테트라히드로-6-트리플루오르메틸-2-헥실옥시-5-히드록시피란으로 구성된 것을 특징으로 하는 광학 활성의 불소함유 화합물.
  8. 제1항에 있어서, 화합물이 테트라히드로-2-부톡시-6-트리플루오르메틸-5-히드록시피란으로 구성된 것을 특징으로 하는 광학 활성의 불소함유 화합물.
  9. 제1항에 있어서, 화합물이 테트라히드로-5-트리플루오르메틸-2-헥실옥시-4-메틸-5-히드록시피란으로 구성된 것을 특징으로 하는 광학 활성의 불소함유 화합물.
  10. 제1항에 있어서, 화합물이 테트라히드로-6-트리플루오르메틸-2-헥실옥시-3-메틸-5-히드록시피란으로 구성된 것을 특징으로 하는 광학 활성의 불소함유 화합물.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019920025150A 1991-12-26 1992-12-23 광학활성의 불소함유 화합물 KR970011461B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP91-344802 1991-12-26
JP3344802A JP2786768B2 (ja) 1991-12-26 1991-12-26 光学活性な含フッ素化合物

Publications (2)

Publication Number Publication Date
KR930012742A true KR930012742A (ko) 1993-07-21
KR970011461B1 KR970011461B1 (ko) 1997-07-11

Family

ID=18372103

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019920025150A KR970011461B1 (ko) 1991-12-26 1992-12-23 광학활성의 불소함유 화합물

Country Status (6)

Country Link
US (1) US5296616A (ko)
EP (1) EP0548947B1 (ko)
JP (1) JP2786768B2 (ko)
KR (1) KR970011461B1 (ko)
DE (1) DE69218372T2 (ko)
TW (1) TW226017B (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443755A (en) * 1991-12-26 1995-08-22 Kashima Oil Company Optically active tetrahydropyrane derivatives, liquid crystal composition and liquid crystal device containing the same
JP2977410B2 (ja) * 1993-04-26 1999-11-15 シャープ株式会社 強誘電性液晶組成物およびこれを用いた素子
DE59408926D1 (de) * 1993-05-19 1999-12-23 Basf Ag Chirale Verbindungen
US5595684A (en) * 1994-04-11 1997-01-21 Kashima Oil Company Optically active tetrahydropyran derivative, liquid crystal composition, and liquid crystal device containing the same
US20050096665A1 (en) * 2003-10-30 2005-05-05 Scimed Life Systems, Inc. Guidewire having a helically contoured portion
US7754460B2 (en) 2003-12-03 2010-07-13 Danisco Us Inc. Enzyme for the production of long chain peracid
US8476052B2 (en) * 2003-12-03 2013-07-02 Danisco Us Inc. Enzyme for the production of long chain peracid
WO2005056782A2 (en) 2003-12-03 2005-06-23 Genencor International, Inc. Perhydrolase
EP1960517A2 (en) * 2005-12-06 2008-08-27 Genencor International, Inc. Perhydrolase epitopes
CA2633849A1 (en) * 2005-12-09 2007-11-22 Genencor International, Inc. Acyl transferase useful for decontamination
EP1991651B2 (en) * 2006-03-02 2022-07-06 The Procter & Gamble Company Surface active bleach at dynamic ph

Also Published As

Publication number Publication date
EP0548947B1 (en) 1997-03-19
DE69218372D1 (de) 1997-04-24
JPH05178849A (ja) 1993-07-20
DE69218372T2 (de) 1997-06-26
JP2786768B2 (ja) 1998-08-13
US5296616A (en) 1994-03-22
TW226017B (ko) 1994-07-01
KR970011461B1 (ko) 1997-07-11
EP0548947A1 (en) 1993-06-30

Similar Documents

Publication Publication Date Title
KR930012742A (ko) 광학활성의 불소함유 화합물
SE7709091L (sv) Flytande kristallint material
ATE199242T1 (de) Fluorsubstituierte flüssigkristalline verbindung, flüssigkristalline zusammensetzung und flüssigkristalline anzeige
CA1246094A (en) HALOGEN ESTERS
KR920018029A (ko) 신규한 카복실산 아미드
KR900017988A (ko) 나프타렌 화합물 및 그를 함유하는 액정 조성물
KR880011073A (ko) 다수의 비대칭 탄소원자를 함유하는 신규의 광학적 활성 화합물
BR9408185A (pt) Método para estabilizar uma composiçao de enzima e composiçao de enzima
KR950032230A (ko) 실라시클로헥산 화합물, 그 제조방법 및 이를 함유하는 액정조성물
KR890006790A (ko) 2,5-디페닐 피리미딘 화합물 및 액정 조성물
KR960704995A (ko) 액정 화합물(liquid-crystalline compounds)
KR940011410A (ko) 공액 에닌 유도체 및 액정 조성물
KR920701379A (ko) 액정 매질
KR910014336A (ko) 클로로 톨란
KR890005055A (ko) 광학 활성-2,5- 디페닐피리딘
KR890006639A (ko) 벤조티아진 디옥사이드 유도체
KR900014300A (ko) 광학활성 화합물, 이 화합물을 함유한 액정 조성물 및 이조성물을 사용한 액정 광변조 장치
DK0708762T3 (da) Fremgangsmåde til fremstilling af HIV protease-inhibitorer
KR970006274A (ko) 나프탈렌화합물, 액정조성물 및 액정소자
KR920701158A (ko) 피리딘 유도체
KR960017682A (ko) 키랄 화합물
KR960700985A (ko) 디사이클로헥실에틸렌 유도체(Dicyclohexylethylene derivative)
EP0829469A3 (en) Racemic compound and anti-ferroelectric liquid crystal composition
KR920701382A (ko) 플루오르화 비페닐 유도체
KR890006791A (ko) 광학활성-2-비비페닐일피리딘

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20031009

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee